Abstract

Using strategies that obtain biomarkers where early symptoms coincide, the early detection of Alzheimer's disease and its complications is essential. Electroencephalogram is a technology that allows thousands of neurons with equal spatial orientation of the duration of cerebral cortex electrical activity to be registered by postsynaptic potential. Therefore, in this paper, the time-dependent power spectrum descriptors are used to diagnose the electroencephalogram signal function from three groups: mild cognitive impairment, Alzheimer's disease, and healthy control test samples. The final feature used in three modes of traditional classification methods is recorded: k-nearest neighbors, support vector machine, linear discriminant analysis approaches, and documented results. Finally, for Alzheimer's disease patient classification, the convolutional neural network architecture is presented. The results are indicated using output assessment. For the convolutional neural network approach, the accurate meaning of accuracy is 82.3%. 85% of mild cognitive impairment cases are accurately detected in-depth, but 89.1% of the Alzheimer's disease and 75% of the healthy population are correctly diagnosed. The presented convolutional neural network outperforms other approaches because performance and the k-nearest neighbors' approach is the next target. The linear discriminant analysis and support vector machine were at the low area under the curve values.

Highlights

  • The term “dementia” refers to many neurodegenerative illnesses caused by neuronal failure and death that interrupt cognitive and behavioral activities

  • The time-dependent power spectrum descriptor (TD-PSD) approach is used for EEG signal feature extraction from three groups of mild cognitive impairment (MCI), Alzheimer’s disease (AD), and Healthy control (HC) test samples

  • The final features used in three conventional classification methods are registered: k-nearest neighboring (KNN), support vector machine (SVM), and linear discriminant analysis (LDA), and the effects are recorded

Read more

Summary

Introduction

The term “dementia” refers to many neurodegenerative illnesses caused by neuronal failure and death that interrupt cognitive and behavioral activities. The National Institute on Aging and Alzheimer’s Association has established the existing standards of clinical diagnosis of AD, and the Alzheimer’s Association has established them [5] These standards are an advancement in the previous guidelines, Computational and Mathematical Methods in Medicine which had been developed in 1984 by the National Institute of Neurological And Communicative Diseases and Stroke/Alzheimer’s Disease and Related Disorders Association (NINCDS-ADRDA) [6]. It is part of the NINCDS-ADRDA guideline. These revised suggestions require neuroimagery and the use of biomarkers and cerebrospinal fluid to diagnose AD for symptomatic people [5]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call